Greenwich LifeSciences Inc. (GLSI) is priced at $40.07 after the most recent trading session. At the very opening of the session, the stock price was $38.07 and reached a high price of $44.98, prior to closing the session it reached the value of $37.85. The stock touched a low price of $37.1015.
Recently in News on December 22, 2020, Greenwich LifeSciences, Inc. Announces Closing of Public Offering of Common Stock. Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the closing of its previously announced underwritten public offering of common stock, resulting in gross proceeds to the Company of $26.4 million.. The Company intends to use the net proceeds for completion of all manufacturing and all clinical trial activities to complete an interim analysis and data readout of the GP2 Phase III clinical trial, for the submission of a Biologics Licensing Application to the FDA seeking conditional marketing approval of GP2, for the in-licensing or acquisition and development of additional products, including the coronavirus vaccine program, and for working capital and general corporate purposes. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Greenwich LifeSciences Inc. shares are logging -74.65% during the 52-week period from high price, and 1128.39% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.26 and $158.07.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1253571 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Greenwich LifeSciences Inc. (GLSI) recorded performance in the market was 701.40%. At the time of this writing, the total market value of the company is set at 560.98M.
Greenwich LifeSciences Inc. (GLSI) in the eye of market guru’s
During the last month, 0 analysts gave the Greenwich LifeSciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GLSI is recording 0.13 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Greenwich LifeSciences Inc. (GLSI): Stocks Technical analysis and Trends
Raw Stochastic average of Greenwich LifeSciences Inc. in the period of last 50 days is set at 23.78%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 22.91%. In the last 20 days, the company’s Stochastic %K was 21.70% and its Stochastic %D was recorded 21.95%.
If we look into the earlier routines of Greenwich LifeSciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 701.40%. The shares increased approximately by -17.70% in the 7-day charts and went down by 629.87% in the period of the last 30 days.